MCM3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.254200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.447200E-01
Normal-vs-Stage2
9.088800E-01
Normal-vs-Stage3
2.199600E-01
Normal-vs-Stage4
9.382600E-01
Stage1-vs-Stage2
6.452200E-01
Stage1-vs-Stage3
3.012800E-01
Stage1-vs-Stage4
5.647600E-01
Stage2-vs-Stage3
1.524760E-01
Stage2-vs-Stage4
8.170400E-01
Stage3-vs-Stage4
1.842580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.232800E-01
Normal-vs-AfricanAmerican
7.119800E-01
Normal-vs-Asian
6.257800E-01
Caucasian-vs-AfricanAmerican
4.350600E-01
Caucasian-vs-Asian
2.030000E-01
AfricanAmerican-vs-Asian
9.073800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.654600E-01
Normal-vs-Female
9.051800E-01
Male-vs-Female
4.873200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.028800E-01
Normal-vs-Age(41-60Yrs)
8.025000E-01
Normal-vs-Age(61-80Yrs)
8.254800E-01
Normal-vs-Age(81-100Yrs)
7.346200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.904950E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.981000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.220100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.454800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.791800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.462400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.550600E-01
Normal-vs-Daily Drinker
4.444000E-01
Normal-vs-Weekly Drinker
5.949600E-01
Normal-vs-Occasional Drinker
8.518200E-01
Normal-vs-Social Drinker
5.226800E-01
Non Drinker-vs-Daily Drinker
3.500600E-01
Non Drinker-vs-Weekly Drinker
1.280560E-01
Non Drinker-vs-Occasional Drinker
9.240200E-01
Non Drinker-vs-Social Drinker
7.170000E-01
Daily Drinker-vs-Weekly Drinker
6.746500E-02
Daily Drinker-vs-Occasional Drinker
2.578000E-01
Daily Drinker-vs-Social Drinker
4.054200E-01
Weekly Drinker-vs-Occasional Drinker
2.049000E-01
Weekly Drinker-vs-Social Drinker
1.242550E-01
Occasional Drinker-vs-Social Drinker
6.217000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.530400E-01
Normal-vs-Grade 2
8.131800E-01
Normal-vs-Grade 3
8.161600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.120380E-01
Grade 1-vs-Grade 3
1.661640E-01
Grade 1-vs-Grade 4
7.530400E-01
Grade 2-vs-Grade 3
9.225800E-01
Grade 2-vs-Grade 4
8.131800E-01
Grade 3-vs-Grade 4
8.161600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.066000E-01
Normal-vs-NonDiabetic
9.199400E-01
Diabetic-vs-NonDiabetic
1.372400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.780800E-01
Normal-vs-NoPancreatitis
7.825400E-01
Pancreatitis-vs-NoPancreatitis
5.785400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.343000E-01
Normal-vs-N1
8.350200E-01
N0-vs-N1
6.700800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.760000E-01
Normal-vs-TP53-NonMutant
9.494400E-01
TP53-Mutant-vs-TP53-NonMutant
1.195590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
